The Therapeutic Potential of Vaginal Drug Delivery in the Treatment of Cervical Cancer

References

• de Freitas AC Gurgel AP Chagas BS Coimbra EC do Amaral CM . Susceptibility to cervical cancer: an overview. Gynecol. Oncol.1269 (2), 304–311 (2012).
   Google Scholar
• Franco EL Schlecht NF Saslow D . The epidemiology of cervical cancer. Cancer J.9 (5), 348–359 (2003).
   PubMed Web of Science ®Google Scholar
• Nour NM . Cervical cancer: a preventable death. Rev. Obstet. Gynecol.2 (4), 240–244 (2009).
   PubMedGoogle Scholar
• Scarinci IC Garcia FA Kobetz E et al. Cervical cancer prevention: new tools and old barriers. Cancer116 (11), 2531–2542 (2010).
   PubMed Web of Science ®Google Scholar
• Sharma R . HPV vaccine: a breakthrough in prevention of cervical cancer. Apollo Medicine.9 (2), 87–90 (2012).
   Google Scholar
• Denny L . Cytological screening for cervical cancer prevention. Best Pract. Res. Clin. Obstet. Gynaecol.26 (2), 189–196 (2012).
   PubMed Web of Science ®Google Scholar
• Schiffma M Castle PE Jeronimo J Rodriguez AC Wacholder S . Human papillomavirus and cervical cancer. Lancet370 (9590), 890–907 (2007).
   PubMed Web of Science ®Google Scholar
• Chien LN Adams EK Flowers LC . Treating cervical cancer: breast and cervical cancer prevention and treatment act patients. Am. J. Obstet. Gynecol.204 (6), 533–533 (2011).
   Web of Science ®Google Scholar
• Covens A Rosen B Murphy J et al. Changes in the demographics and perioperative care of stage Ia(2)/Ib(1) cervical cancer over the past 16 years. Gynecol. Oncol.81 (2), 133–137 (2001).
   PubMed Web of Science ®Google Scholar
• Gien LT Covens A . Fertility-sparing options for early stage cervical cancer. Gynecol. Oncol.117 (2), 350–357 (2010).
   PubMed Web of Science ®Google Scholar
• Speiser D Köhler C Schneider A Mangler M . Radical Vaginal Trachelectomy: a fertility-preserving procedure in early cervical cancer in young women. Dtsch. Arztebl. Int.110 (17), 289–295 (2013).
   PubMedGoogle Scholar
• Cao DY Yang JX Wu XH et al. China Gynecologic Oncology Group. Comparisons of vaginal and abdominal radical trachelectomy for early-stage cervical cancer: preliminary results of a multi-center research in China. Br. J. Cancer109 (11), 2778–2782 (2013).
   PubMed Web of Science ®Google Scholar
• Roy M Plante M . Pregnancies after radical vaginal trachelectomy for early stage cervical cancer. Am. J. Obstet. Gynecol.179 (6 Pt 1), 1491–1496 (1998).
   PubMed Web of Science ®Google Scholar
• Mathevet P Laszlo de Kaszon E Dargent D . Fertility preservation in early cervical cancer. Gynecol. Obstet. Fertil.31 (9), 706–712 (2003) ( 2003).
   PubMedGoogle Scholar
• Plante M Renaud MC Francois H Harel F . Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An update series of 72 cases and review of the literature. Gynecol. Oncol.94 (3), 614–623 (2004) ( 2004).
   PubMed Web of Science ®Google Scholar
• Nishio H Fujii T Kameyama K et al. Abdominal radical trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer in a series of 61 women. Gynecol. Oncol.115 (1), 51–55 (2009).
   PubMed Web of Science ®Google Scholar
• Rob L Pluta M Skapa P Robova H . Advanced in fertility-sparing surgery for cervical cancer. Expert Rev. Anticancer Ther.10 (7), 1101–1114 (2010).
   PubMed Web of Science ®Google Scholar
• Rob L Skapa P Robova H . Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol.12 (2), 192–200 (2011).
   PubMed Web of Science ®Google Scholar
• Robova H Halaska M Pluta M et al. The role of neoadjuvant chemotherapy and surgery in cervical cancer. Int. J. Gynecol. Cancer20 (11 Suppl. 2), S42–46 (2010).
   PubMed Web of Science ®Google Scholar
• Robova H Rob L Halaska MJ et al. High-dose density neo-adjuvant chemotherapy in bulky IB cervical cancer. Gynecol. Oncol.128 (1), 49–53 (2013).
   PubMed Web of Science ®Google Scholar
• Benedetti-Panici P Greggi S Colombo A et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cellcervical cancer: result from the Italian multicentre randomized study. J. Clin. Oncol.20 (1), 179–188 (2002).
   PubMed Web of Science ®Google Scholar
• Wolinsky JB Colson YL Grinstaff MW . Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers. J. Con. Rel.159 (1), 14–26 (2012).
   PubMed Web of Science ®Google Scholar
• Friend D . Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections. Drug Deliv. Transl. Res.1 (3), 185–193 (2011).
   PubMed Web of Science ®Google Scholar
• Loxley A Mitchnick M Okoh O et al. Ethylene vinyl acetate intravaginal rings for the simultaneous delivery of the antiretroviral UC781 and contraceptive levonorgestrel. Drug Deliv. Transl. Res.1 (3), 247–255 (2011).
   PubMed Web of Science ®Google Scholar
• Malcolm RK Woolfson AD Toner CF Morrow RJ McCullagh SD . Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings. J. Antimicrob. Chemother.56 (5), 954–956 (2005).
   PubMed Web of Science ®Google Scholar
• McConville C Major I Friend DR Clark MR Malcolm RM . Development of a UC781 releasing poly ethylene vinyl acetate vaginal ring. Drug Deliv. Transl. Res.2 (6) 489–497 (2012).
   PubMed Web of Science ®Google Scholar
• McConville C Friend DR Clark MR Malcolm K . Preformulation and development of a once-daily sustained-release tenofovir vaginal tablet containing a single excipient. J. Pharm. Sci.102 (6), 1859–1866 (2013).
   PubMed Web of Science ®Google Scholar
• Malcolm RM Forbes CJ Geer L et al. Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques. J. Antimicrob. Chemother.68 (3), 678–683 (2013).
   PubMed Web of Science ®Google Scholar
• Karim AQ Karim SSA Frohlich JA et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science329 (5996), 1168–1174 (2010).
   PubMed Web of Science ®Google Scholar
• Malcolm RK McCullagh SD Morrow RJ Woolfson AD . Vagina and uterus as drug-absorbing organs. In : Enhancement in Drug Delivery.TouitouEBarryBW ( Eds). CRC Press, Boca Raton, FL, USA, 395–431 (2006).
   Google Scholar
• Woolfson AD Malcolm RK Gallagher R . Drug delivery by the intravaginal route. Crit. Rev. Ther. Drug Carrier Syst.17 (5), 509–555 (2000).
   PubMed Web of Science ®Google Scholar
• Woolfson AD McCafferty DF McCarron PA Price JH . A bioadhesive patch cervical drug delivery system for the administration of 5-fluorouracil to cervical tissue. J. Con. Rel.35 (1), 49–58 (1995).
   Web of Science ®Google Scholar
• Graham V Surwit ES Weiner S Meyskens FL . Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap. West. J. Med.145 (2), 192–195 (1986).
   PubMedGoogle Scholar
• Kirwan P Naftalin NJ . Topical 5-fluorouracil in the treatment of vaginal intraepithelial neoplasia. Br. J. Obstet. Gynaecol.92 (3), 287–291 (1985).
   PubMedGoogle Scholar
• Keskar V Mohanty PS Gemeinhart EJ Gemeinhart RA . Cervical cancer treatment with a locally insertable controlled release delivery system. J. Con. Rel.115 (3), 280–288 (2006).
   PubMed Web of Science ®Google Scholar
• Hodge LS Downs LS Chura LC et al. Localized delivery of chemotherapy to the cervix for radiosensitization. Gynecol. Oncol.127 (1), 121–125 (2012).
   PubMed Web of Science ®Google Scholar
• Bilensoy E Çırpanlı Y Şen M Doğan AL Çalış S . Thermosensitive mucoadhesive gel formulation loaded with 5-Fu: cyclodextrin complex for HPV-induced cervical cancer. J. Incl. Phenom. Macrocycl. Chem.57 (1–4), 363–370 (2007).
   Web of Science ®Google Scholar
• Cicinelli E DeZiegler D Morgese S et al. “First uterine pass effect” is observed when estradiol is placed in the upper but not lower third of the vagina. Fertil Steril.81, 1414–1416 (2004).
   PubMed Web of Science ®Google Scholar
• Debata PR Castellanos MR Fata JE et al. A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells. Gynecol. Oncol.129 (1), 145–153 (2013).
   PubMed Web of Science ®Google Scholar
• Snoeck R Noel JC Muller C De Clercq E Bossens M . Cidofovir. A new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III). J. Med. Virol.60 (2), 205–209 (2000).
   PubMed Web of Science ®Google Scholar
• Snoeck R Bossens M Parent D et al. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection. Clin. Infect. Dis.33 (5), 597–602 (2001).
   PubMed Web of Science ®Google Scholar
• Baffoe CS Nguyen N Boyd P Wang W Morris M McConville C . Disulfiram-loaded immediate and extended release vaginal tablets for the localised treatment of cervical cancer. J. Pharm. Pharmacol.67 (2), 189–198 (2015).
   PubMed Web of Science ®Google Scholar
• Wickström M Danielsson K Rickardson L et al. Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients. Biochem. Pharmacol.73 (1), 25–33 (2006).
   PubMed Web of Science ®Google Scholar
• Yip NC Fombon IS Liu P et al. Disulfiram modulated ROS–MAPK and NFkB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br. J. Cancer104 (10), 1564–1574 (2011).
   PubMed Web of Science ®Google Scholar
• Liu P Brown S Goktug T et al. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. Br. J. Cancer107 (9), 1488–1497 (2012).
   PubMed Web of Science ®Google Scholar
• Chen D Cui QC Yang H Dou QP . Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res.66 (21), 10425–10433 (2006).
   PubMed Web of Science ®Google Scholar
• Iljin K Ketola K Vainio P et al. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth. Clin. Cancer Res.15 (19), 6070–6078 (2009).
   PubMed Web of Science ®Google Scholar
• Ketola K Kallioniemi O Iljin K . Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells. PLoS ONE7, e51470 (2012).
   PubMed Web of Science ®Google Scholar
• Minagawa Y Kigawa J Itamochi H et al. Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways. Jpn. J. Cancer Res.90 (12), 1373–1379 (1999).
   PubMedGoogle Scholar
• Brar SS Grigg C Wilson KS et al. Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease. Mol. Cancer Ther.3 (9), 1049–1060 (2004).
   PubMed Web of Science ®Google Scholar
• Dufour P Lang JM Giron C et al. Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study. Biotherapy6 (1), 9–12 (1993).
   PubMedGoogle Scholar
• Verma S Stewart DJ Maroun JA Nair RC . A randomized Phase II study of cisplatin alone versus cisplatin plus disulfiram. Am. J. Clin. Oncol.13 (2), 119–124 (1990).
   PubMed Web of Science ®Google Scholar
• Pendekal MS Tegginamat PK . Hybrid drug delivery system for oropharyngeal, cervical and colorectal cancer–in vitro and in vivo evaluation. Saudi. Pharm. J.21 (2), 177–186 (2013).
   PubMed Web of Science ®Google Scholar
• Stefani C Liverani CA Bianco V et al. Spontaneous regression of low-grade cervical intraepithelial lesions is positively improved by topical bovine colostrum preparations (GINEDIE®). A multicentre, observational, Italian pilot study. Eur. Rev. Med. Pharmacol. Sci.18 (5), 728–733 (2014).
   PubMed Web of Science ®Google Scholar
• Shukla S Bharti AC Hussain S et al. Elimination of high-risk human papillomavirus type HPV16 infection by ‘Praneem’ polyherbal tablet in women with early cervical intraepithelial lesions. J. Cancer Res. Clin. Oncol.135 (12), 1701–1709 (2009).
   PubMed Web of Science ®Google Scholar
• Woolfson AD Elliott GRE Gilligan CA Passmore CM . Design of an intravaginal ring for the controlled delivery of 17beta-estradiol as its 3-acetate ester. J. Con. Rel.61 (3), 319–328 (1999).
   PubMed Web of Science ®Google Scholar
• Malcolm RK . Vaginal rings for controlled release drug delivery. In : Modified Release Drug Delivery Technology (2nd ed.).RathboneMJHadgraftJRobertsMSLaneME ( Eds). Informa Healthcare, New York, USA, 499–510 (2008).
   Google Scholar
• Brucker C Karck U Merkle E . Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing®: results of clinical experience in Germany. Eur. J. Contracept. Reprod. Health Care.13 (1), 31–38 (2008).
   PubMed Web of Science ®Google Scholar
• Woolfson AD Malcolm RK Gallagher RJ . Design of a silicone reservoir intravaginal ring for the delivery of oxybutynin. J. Con. Rel.91 (3) 465–476 (2003).
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ Nisand I Bastianelli C et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 mg of ethinyl estradiol and 3 mg of drospirenone. Contraception74 (6), 451–457 (2006).
   PubMed Web of Science ®Google Scholar
• Chaplin S Peers T . NuvaRing: new combined hormonal contraceptive device. Prescriber20 (12), 17–20 (2009).
   Google Scholar
• Henriksson L Stjernquist M Boquist L Cedergren I Selinus I . A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging. Am. J. Obstet. Gynecol.74 (1 Pt 1), 85–92 (1996).
   Google Scholar
• Boyd P Major I Wang W McConville C . Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer. Eur. J. Pharm. Biopharm.88, 945–953 (2014).
   PubMed Web of Science ®Google Scholar
• Graham V Surwit ES Weiner S Meyskens FL . Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap. West J. Med.145 (2), 192–195 (1986).
   PubMedGoogle Scholar
• Meyskens FL Surwit E Moon TE et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J. Natl. Cancer Inst.86 (7), 539–543 (1994).
   PubMedGoogle Scholar
• Ruffin MT Bailey JM Normolle DP et al. Low-dose topical delivery of all-trans retinoic acid for cervical intraepithelial neoplasia II and III. Cancer Epidemiol. Biomarkers Prev.13 (12), 2148–2152 (2004).
   PubMed Web of Science ®Google Scholar
• Hodge LS Downs LS Jr Chura JC et al. Localized delivery of chemotherapy to the cervix for radiosensitization. Gynecol Oncol.127 (1), 121–125 (2012).
   PubMed Web of Science ®Google Scholar
• McCarron PA Woolfson AD McCafferty DF Price JH Sidhub H Hickey GI . Cytotoxicity of 5-fluorouracil released from a bioadhesive patch into uterine cervical tissue. Int. J. Pharm.151 (1), 69–74 (1997).
   Google Scholar
• Sidhu HK Price JH McCarron PA et al. A randomised controlled trial evaluating a novel cytotoxic drug delivery system for the treatment of cervical intraepithelial neoplasia. Br. J. Obstet. Gynaecol.104 (2), 145–149 (1997).
   PubMedGoogle Scholar
• Donnelly RF McCarron PA Zawislak AA Woolfson AD . Design and physicochemical characterisation of a bioadhesive patch for dose-controlled topical delivery of imiquimod. Int. J. Pharm.307 (2), 318–325 (2006).
   PubMedGoogle Scholar
• Hiorth M Liereng L Reinertsen R Tho I . Formulation of bioadhesive hexylaminolevulinate pellets intended for photodynamic therapy in the treatment of cervical cancer. Int. J. Pharm.441 (1–2), 544–554 (2013).
   PubMedGoogle Scholar
• Ensign LM Cone R Hanes J . Nanoparticle-based drug delivery to the vagina: a review. J Control Release.190, 500–514 (2014).
   PubMed Web of Science ®Google Scholar
• Yang M Lai SK Wang YY et al. Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. Angew Chem. Int. Ed. Engl.50 (11), 2597–2600 (2011).
   PubMed Web of Science ®Google Scholar
• Yang M Yu T Wang YY et al. Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth. Adv. Healthc. Mater.3 (7), 1044–1052 (2014).
   PubMed Web of Science ®Google Scholar
• Zeng X Tao W Mei L Huang L Tan C Feng SS . Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials34 (25), 6058–6067 (2013).
   PubMed Web of Science ®Google Scholar
• Saengkrit N Saesoo S Srinuanchai W Phunpee S Ruktanonchai UR . Influence of curcumin-loaded cationic liposome on anticancer activity for cervical cancer therapy. Colloids Surf. B Biointerfaces114, 349–356 (2014).
   PubMed Web of Science ®Google Scholar
• Chen MX Li BK Yin DK Liang J Li SS Peng DY . Layer-by-layer assembly of chitosan stabilized multilayered liposomes for paclitaxel delivery. Carbohydr. Polym.111, 298–304 (2014).
   PubMed Web of Science ®Google Scholar
• Gabizon AA . Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res.52, 891–896 (1992).
   PubMed Web of Science ®Google Scholar
• Harrington KJ Mohammadtaghi S Uster PS et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin. Cancer Res.7, 243–254 (2001).
   PubMed Web of Science ®Google Scholar
• Zheng J Jaffray D Allen C . Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model. Mol. Pharm.6, 571–580 (2009).
   PubMedGoogle Scholar
• Dunne M Zheng J Rosenblat J Jaffray DA Allen C . APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes. J. Control. Release154, 298–305 (2011).
   PubMed Web of Science ®Google Scholar
• Stapleton S Allen C Pintilie M Jaffray DA . Tumor perfusion imaging predicts the intra-tumoral accumulation of liposomes. J. Control Release172 (1), 351–357 (2013).
   PubMed Web of Science ®Google Scholar